TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06254950 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-30 → 2026-07-14 3. enrollment: 207 → 213 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06254950 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-30 → 2026-07-14 3. enrollment: 207 → 213 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical